Wan Huan-ying

Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial

Fuqiang Wen, Chunxue Bai, Wan Huan-ying et al. · The Lancet Respiratory Medicine · 2014 · 257 citations

Medicine, Pharmacology, Pharmacotherapy +17

Genetic polymorphism in matrix metalloproteinase-9 and the susceptibility to chronic obstructive pulmonary disease in Han population of south China.

Min Zhou, Shao-Guang Huang, Wan Huan-ying et al. · PubMed · 2004 · 64 citations

Life Sciences, Genetics, Molecular Genetics +16

Quantification of Circulating Cell-Free DNA in the Serum of Patients with Obstructive Sleep Apnea–Hypopnea Syndrome

Liang Ye, Guan-hua Ma, Ling Chen et al. · Lung · 2010 · 40 citations

Medicine, Internal Medicine, Molecular Biology +9

TWICE DAILY N-ACETYLCYSTEINE 600 MG FOR EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (PANTHEON): A RANDOMISED, DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL

Fu-Qiang Wen, Chunxue Bai, Wan Huan-ying et al. · PULMONOLOGIYA · 2014 · 32 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

High-Dose N-Acetylcysteine in the Prevention of COPD Exacerbations: Rationale and Design of the PANTHEON Study

Fuqiang Wen, Chunxue Bai, Wan Huan-ying et al. · COPD Journal of Chronic Obstructive Pulmonary Disease · 2012 · 23 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17